Trajenta Tablets 5mg, from Nippon Boehringer Ingelheim, contains Linagliptin, a DPP-4 inhibitor used as an adjunct to diet and exercise to improve glycemic control in type 2 diabetes. It is a 5mg 1 tablet with YJ code 3969014F1024.
Trajenta Tablets 5mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →